A detailed history of Fjarde Ap Fonden transactions in Royalty Pharma PLC stock. As of the latest transaction made, Fjarde Ap Fonden holds 94,550 shares of RPRX stock, worth $2.57 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
94,550
Previous 113,850 16.95%
Holding current value
$2.57 Million
Previous $3.2 Million 10.23%
% of portfolio
0.03%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$27.46 - $31.33 $529,978 - $604,669
-19,300 Reduced 16.95%
94,550 $2.87 Million
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $838,720 - $935,040
32,000 Added 39.1%
113,850 $3.2 Million
Q3 2023

Oct 23, 2023

SELL
$26.26 - $31.38 $186,446 - $222,798
-7,100 Reduced 7.98%
81,850 $2.22 Million
Q2 2023

Aug 02, 2023

SELL
$29.6 - $36.56 $1.29 Million - $1.59 Million
-43,600 Reduced 32.89%
88,950 $2.73 Million
Q1 2023

May 15, 2023

BUY
$32.77 - $39.4 $961,799 - $1.16 Million
29,350 Added 28.44%
132,550 $4.78 Million
Q4 2022

Feb 14, 2023

SELL
$39.17 - $44.04 $238,937 - $268,644
-6,100 Reduced 5.58%
103,200 $4.08 Million
Q2 2022

Aug 11, 2022

SELL
$37.53 - $44.22 $1.22 Million - $1.44 Million
-32,600 Reduced 22.97%
109,300 $4.6 Million
Q1 2022

May 13, 2022

BUY
$37.46 - $42.44 $801,644 - $908,216
21,400 Added 17.76%
141,900 $5.53 Million
Q4 2021

Feb 15, 2022

BUY
$35.17 - $42.48 $2.03 Million - $2.45 Million
57,600 Added 91.57%
120,500 $4.8 Million
Q3 2021

Nov 15, 2021

BUY
$36.14 - $42.24 $25,298 - $29,568
700 Added 1.13%
62,900 $2.27 Million
Q2 2021

Aug 12, 2021

SELL
$39.85 - $46.63 $179,325 - $209,835
-4,500 Reduced 6.75%
62,200 $2.55 Million
Q1 2021

May 17, 2021

BUY
$42.34 - $52.82 $1.03 Million - $1.28 Million
24,300 Added 57.31%
66,700 $2.91 Million
Q4 2020

Feb 12, 2021

BUY
$36.12 - $50.05 $1.53 Million - $2.12 Million
42,400 New
42,400 $2.12 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.9B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Fjarde Ap Fonden Portfolio

Follow Fjarde Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.